Literature DB >> 2866333

Bites by Russell's viper (Vipera russelli siamensis) in Burma: haemostatic, vascular, and renal disturbances and response to treatment.

D A Warrell, R E Phillips.   

Abstract

Of 123 patients with proved Russell's viper bite, 28% showed no evidence of envenoming, 28% had local swelling alone, but 44% had systemic envenoming manifested by incoagulable blood (100% of those admitted before treatment), thrombocytopenia (26%), spontaneous systemic bleeding (20%), hypotension (35%), evidence of increased capillary permeability (24%), and oliguria (44%). Patients with systemic envenoming usually had more local swelling than those without, but 5 had no local signs. Snake length correlated with the amount of local swelling, but snakes causing systemic envenoming were no longer than those causing local or no envenoming. Burma Pharmaceutical Industry monospecific antivenom was rapidly effective in restoring blood coagulability but did not prevent the development of renal failure even when given within 4 h of the bite. Hypotension responded to volume expanders (11/19 cases) and dopamine (6/7 cases) but not to naloxone (0/3) or high-dose methylprednisolone (0/5). The 10 deaths (8%) were attributed to hypotension, pituitary haemorrhage, and renal failure.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2866333     DOI: 10.1016/s0140-6736(85)91550-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  31 in total

1.  Bungarus multicinctus multicinctus Snakebite in Taiwan.

Authors:  Yan-Chiao Mao; Po-Yu Liu; Liao-Chun Chiang; Shu-Chen Liao; Hung-Yuan Su; Szu-Yin Hsieh; Chen-Chang Yang
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

Review 2.  Traditional use of plants against snakebite in Indian subcontinent: a review of the recent literature.

Authors:  Abhijit Dey; Jitendra Nath De
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-10-02

3.  Predictors of hypopituitarism due to vasculotoxic snake bite with acute kidney injury.

Authors:  Sowrabha Bhat; Pradip Mukhopadhyay; Arpita Raychaudhury; Subhankar Chowdhury; Sujoy Ghosh
Journal:  Pituitary       Date:  2019-12       Impact factor: 4.107

Review 4.  Snake-bites: appraisal of the global situation.

Authors:  J P Chippaux
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

5.  A study on the clinico-epidemiological profile and the outcome of snake bite victims in a tertiary care centre in southern India.

Authors:  Halesha B R; Harshavardhan L; Lokesh A J; Channaveerappa P K; Venkatesh K B
Journal:  J Clin Diagn Res       Date:  2012-09-14

6.  Neurotoxicity in Sri Lankan Russell's Viper (Daboia russelii) Envenoming is Primarily due to U1-viperitoxin-Dr1a, a Pre-Synaptic Neurotoxin.

Authors:  Anjana Silva; Sanjaya Kuruppu; Iekhsan Othman; Robert J A Goode; Wayne C Hodgson; Geoffrey K Isbister
Journal:  Neurotox Res       Date:  2016-07-11       Impact factor: 3.911

7.  Myasthenic syndrome of snake envenomation: a clinical and neurophysiological study.

Authors:  P S Sanmuganathan
Journal:  Postgrad Med J       Date:  1998-10       Impact factor: 2.401

8.  Complementary medicine. The practice of acupuncture needs tighter safeguards.

Authors:  P Baldry
Journal:  BMJ       Date:  1993-07-31

9.  Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria.

Authors:  Isa S Abubakar; Saidu B Abubakar; Abdulrazaq G Habib; Abdulsalam Nasidi; Nandul Durfa; Peter O Yusuf; Solomon Larnyang; John Garnvwa; Elijah Sokomba; Lateef Salako; R David G Theakston; Ed Juszczak; Nicola Alder; David A Warrell
Journal:  PLoS Negl Trop Dis       Date:  2010-07-27

10.  Acute kidney injury following Russell's viper bite in the pediatric population: a 6-year experience.

Authors:  Rajesh Waikhom; Vikas Makkar; Dipankar Sarkar; Krishna Patil; Ametasver Singh; Mahesh Bennikal
Journal:  Pediatr Nephrol       Date:  2013-08-28       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.